DepoCyte
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Neoplastic meningitis (NM) is diagnosed in 1–2 % of patients with primary brain tumors. Standard treatment of NM includes single…
Liposomal cytarabine (Depocyte ® ) is a slow-release formulation of cytarabine designed for intrathecal administration, ensuring…
Introduction Since the landmark study of Omura et al. ( Blood 1980;55:199), validating cranial irradiation as an adjunct to…
Neoplastic meningitis from breast cancer often leads to a progressive neurologic deterioration followed by fatal outcome. The…
Abstract 4411 Background Leptomeningeal disease (LD) is an uncommon and severe complication in the course of B-CLL and may occur…
The treatment of meningeal relapse in acute lymphoblastic leukemia (ALL) remains a challenging clinical problem. Liposomal…
JO N 3 01 4 therapy (WBRT) and MTX lead to severe neurotoxic side effects [5]. Liposomal cytarabin (DepoCyte) may be an…
Patients with diffuse large B-cell lymphoma (DLBCL) who develop lymphomatous meningitis (LM) during or after first-line treatment…
The Lymphomatous Meningitis (LM) is an uncommon event, either as an initial diagnosis and in the course (or as an outcome) of a…
Fanconi's anaemia is the commonest type. It is characterised by multiple congenital abnormalities that vary from patient to…